Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Format: Artigo
Language:Inglês
Published: BMC 2017-11-01
Series:BMC Pulmonary Medicine
Subjects:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
Online Access:http://link.springer.com/article/10.1186/s12890-017-0503-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items